Skip to content

Chronic Effects of High-Temperature Exposure on Metabolic Health in the General Population: A Prospective, Single-Center, Observational Cohort Study

Chronic Effects of High-Temperature Exposure on Metabolic Health in the General Population: A Prospective, Single-Center, Observational Cohort Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080242
Enrollment
Unknown
Registered
2024-01-24
Start date
2024-03-28
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic diseases

Interventions

Control Group:None
Exposed Group:None

Sponsors

The First People's Hospital of Xiangtan City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. 18.5 <= BMI <= 28; 2. 18 <= Age <= 55 years old; 3. Physical and mental health; 4. Participants themselves and their immediate family members comprehensively understand the informed consent form, agree to participate in the study, and sign the informed consent document.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with metabolic-related conditions such as obesity, type 2 diabetes, hypertension, etc.; 2. Afflicted with conditions that may cause metabolic disturbances such as Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, hypothalamic-pituitary disorders, insulinoma, etc.; 3. Long-term use of steroids or other medications that may impact metabolism; 4. Excessive alcohol consumers (consuming over 14 units of alcohol per week, where 1 unit equals 360 mL of beer, 45 mL of 40% alcohol, or 150 mL of wine); 5. Pregnant or lactating women, women planning pregnancy within the trial period (12 months), and women at high risk of pregnancy who are not using any contraceptive measures; 6. Presence of any other medical history considered by the investigators to potentially prevent compliance with or completion of the study protocol, such as hepatic or renal insufficiency, malignancy, cardiovascular diseases, mental illnesses, and other severe conditions; 7. Inability of the patient or close relatives to comprehend or sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Body Mass Index (BMI);

Secondary

MeasureTime frame
waist circumference;hip circumference;glycemic markers;lipid metabolism markers;

Countries

China

Contacts

Public ContactGenqing Xie

The First People's Hospital of Xiangtan City

genqingxie@qq.com+86 181 6360 2595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026